{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,6]],"date-time":"2026-10-06T23:29:37Z","timestamp":1791329377670,"version":"4.3.1"},"reference-count":21,"publisher":"Springer Science and Business Media LLC","issue":"4","license":[{"start":{"date-parts":[[2011,1,25]],"date-time":"2011-01-25T00:00:00Z","timestamp":1295913600000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Br J Cancer"],"published-print":{"date-parts":[[2011,2]]},"DOI":"10.1038\/sj.bjc.6606086","type":"journal-article","created":{"date-parts":[[2011,1,25]],"date-time":"2011-01-25T20:59:50Z","timestamp":1295989190000},"page":"587-592","source":"Crossref","is-referenced-by-count":28,"title":["Development of a questionnaire (EORTC module) to measure quality of life in patients with cholangiocarcinoma and gallbladder cancer, the EORTC QLQ-BIL21"],"prefix":"10.1038","volume":"104","author":[{"name":"on behalf of the EORTC Quality of Life Group","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"E","family":"Friend","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"G","family":"Yadegarfar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"C","family":"Byrne","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"C D","family":"Johnson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"O","family":"Sezer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S","family":"Pucciarelli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S P","family":"Pereira","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"W-C","family":"Chie","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A","family":"Banfield","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J K","family":"Ramage","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2011,1,25]]},"reference":[{"issue":"15_suppl","key":"BF6606086_CR1","doi-asserted-by":"publisher","first-page":"15564","DOI":"10.1200\/jco.2008.26.15_suppl.15564","volume":"26","author":"K. Ahmed","year":"2008","unstructured":"Ahmed K, Beg MS, Komrokji R, Safa MM (2008) Intrahepatic versus extrahepatic cholangiocarcinoma: is there a difference in survival? J Clin Oncol 26(suppl): (abstract 15564)","journal-title":"Journal of Clinical Oncology"},{"key":"BF6606086_CR2","doi-asserted-by":"publisher","first-page":"43","DOI":"10.1634\/theoncologist.9-1-43","volume":"9","author":"CD Anderson","year":"2004","unstructured":"Anderson CD, Pinson CW, Berlin J, Chari RS (2004) Diagnosis and treatment of cholangiocarcinoma. The Oncologist 9: 43\u201357","journal-title":"The Oncologist"},{"issue":"3","key":"BF6606086_CR3","doi-asserted-by":"publisher","first-page":"772","DOI":"10.1016\/j.ijrobp.2006.05.061","volume":"66","author":"MA Ben David","year":"2006","unstructured":"Ben David MA, Griffith KA, Abu-Isa E, Lawrence TS, Knol J, Zalupski M, Ben-Josef E (2006) External-beam radiotherapy for localized extrahepatic cholangiocarcinoma. Int J Radiat Oncol Biol Phys 66 (3): 772\u2013779","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"BF6606086_CR4","volume-title":"EORTC Quality of Life Group Guidelines for Developing Questionnaire Modules","author":"J Blazeby","year":"2002","unstructured":"Blazeby J, Sprangers M, Cull A, Groenvold M, Bottomley A (2002) EORTC Quality of Life Group Guidelines for Developing Questionnaire Modules, 3rd edn. revised EORTC Quality of Life Group"},{"issue":"5","key":"BF6606086_CR5","doi-asserted-by":"publisher","first-page":"755","DOI":"10.1097\/01.sla.0000251366.62632.d3","volume":"245","author":"ML DeOliveira","year":"2007","unstructured":"DeOliveira ML, Cunningham SC, Cameron JL, Kamangar F, Winter JM, Lillemoe KD, Choti MA, Yeo CJ, Schulick RD (2007) Cholangiocarcinoma: thirty-one-year experience with 564 patients at a single institution. Ann Surg 245 (5): 755\u2013762","journal-title":"Ann Surg"},{"key":"BF6606086_CR6","volume-title":"EORTC Quality of Life Group Translation Procedure","author":"L Dewolf","year":"2009","unstructured":"Dewolf L, Koller M, Velikova G, Scott N, Bottomley A (2009) EORTC Quality of Life Group Translation Procedure, 3rd edn. EORTC Quality of Life Group"},{"issue":"6","key":"BF6606086_CR7","doi-asserted-by":"publisher","first-page":"939","DOI":"10.1016\/S0959-8049(99)00047-7","volume":"35","author":"D Fitzsimmons","year":"1999","unstructured":"Fitzsimmons D, Johnson CD, George S, Payne S, Sandberg AA, Bassi C, Beger HG, Birk D, B\u00fcchler MW, Dervenis C, Fernandez Cruz L, Friess H, Grahm AL, Jeekel J, Laugier R, Meyer D, Singer MW, Tihanyi T (1999) Development of a disease specific quality of life (QoL) questionnaire module to supplement the EORTC core cancer QoL questionnaire, the QLQ-C30 in patients with pancreatic cancer. Eur J Cancer 35 (6): 939\u2013941","journal-title":"Eur J Cancer"},{"issue":"Suppl 111","key":"BF6606086_CR8","first-page":"iii1","volume":"55","author":"O Garden","year":"2006","unstructured":"Garden O, Rees M, Poston GJ, Mirza D, Saunders M, Ledermann J, Primrose JN, Parks RW (2006) Guidelines for resection of colorectal cancer liver metastases. Gut 55 (Suppl 111): iii1\u2013iii8","journal-title":"Gut"},{"issue":"9","key":"BF6606086_CR9","doi-asserted-by":"publisher","first-page":"2229","DOI":"10.1200\/JCO.2002.07.093","volume":"20","author":"N Heffernan","year":"2002","unstructured":"Heffernan N, Cella D, Webster K, Odom L, Martone M, Passik S, Bookbinder M, Fong Y, Jarnagin W, Blumgart L (2002) Measuring health-related quality of life in patients with hepatobiliary cancers: the functional assessment of cancer therapy-hepatobiliary questionnaire. J Clin Oncol 20 (9): 2229\u20132239","journal-title":"J Clin Oncol"},{"issue":"3","key":"BF6606086_CR10","doi-asserted-by":"publisher","first-page":"321","DOI":"10.1007\/s00280-006-0380-9","volume":"60","author":"YS Hong","year":"2007","unstructured":"Hong YS, Lee J, Lee SC, Hwang IG, Choi SH, Heo JS, Park JO, Park YS, Lim HY, Kang WK (2007) Phase II study of capecitabine and cisplatin in previously untreated advanced biliary tract cancer. Cancer Chemother Pharmacol 60 (3): 321\u2013328","journal-title":"Cancer Chemother Pharmacol"},{"key":"BF6606086_CR11","doi-asserted-by":"publisher","first-page":"848","DOI":"10.1046\/j.1440-1746.2001.02520.x","volume":"16","author":"SP Kaushik","year":"2001","unstructured":"Kaushik SP (2001) Current perspectives in gall bladder carcinoma. J Gastroenterol Hepatol 16: 848\u2013854","journal-title":"J Gastroenterol Hepatol"},{"key":"BF6606086_CR12","doi-asserted-by":"publisher","first-page":"1259","DOI":"10.1016\/S0959-8049(03)00236-3","volume":"39","author":"V Kavadas","year":"2003","unstructured":"Kavadas V, Blazeby JM, Conroy T, Sezer O, Holzner B, Koller M, Buckels J (2003) Development of an EORTC disease-specific quality of life questionnaire for use in patients with liver metastases from colorectal cancer. Eur J Cancer 39: 1259\u20131263","journal-title":"Eur J Cancer"},{"key":"BF6606086_CR13","doi-asserted-by":"publisher","first-page":"1303","DOI":"10.1016\/S0140-6736(05)67530-7","volume":"366","author":"SA Khan","year":"2005","unstructured":"Khan SA, Thomas HC, Davidson BR, Taylor-Robinson SD (2005) Cholangiocarcinoma. Lancet 366: 1303\u20131314","journal-title":"Lancet"},{"issue":"2","key":"BF6606086_CR14","doi-asserted-by":"publisher","first-page":"77","DOI":"10.1080\/13651820801992641","volume":"10","author":"SA Khan","year":"2008","unstructured":"Khan SA, Toledano MB, Taylor-Robinson SD (2008) Epidemiology, risk factors, and pathogenesis of cholangiocarcinoma. HPB (Oxford) 10 (2): 77\u201382","journal-title":"HPB (Oxford)"},{"issue":"6","key":"BF6606086_CR15","doi-asserted-by":"publisher","first-page":"856","DOI":"10.1016\/j.jhep.2006.09.001","volume":"45","author":"H Malhi","year":"2006","unstructured":"Malhi H, Gores GJ (2006) Cholangiocarcinoma: modern advances in understanding a deadly old disease. J Hepatol 45 (6): 856\u2013867","journal-title":"J Hepatol"},{"issue":"6","key":"BF6606086_CR16","doi-asserted-by":"publisher","first-page":"1198","DOI":"10.1158\/1055-9965.EPI-05-0811","volume":"15","author":"KA McGlynn","year":"2006","unstructured":"McGlynn KA, Tarone RE, El Serag HB (2006) A comparison of trends in the incidence of hepatocellular carcinoma and intrahepatic cholangiocarcinoma in the United States. Cancer Epidemiol Biomarkers Prev 15 (6): 1198\u20131203","journal-title":"Cancer Epidemiol Biomarkers Prev"},{"issue":"3","key":"BF6606086_CR17","doi-asserted-by":"publisher","first-page":"317","DOI":"10.1097\/MOG.0b013e3280495451","volume":"23","author":"T Patel","year":"2007","unstructured":"Patel T, Singh P (2007) Cholangiocarcinoma: emerging approaches to a challenging cancer. Curr Opin Gastroenterol 23 (3): 317\u2013323","journal-title":"Curr Opin Gastroenterol"},{"key":"BF6606086_CR18","doi-asserted-by":"publisher","first-page":"115","DOI":"10.1055\/s-2004-828889","volume":"24","author":"Y Shaib","year":"2004","unstructured":"Shaib Y, El-Serag HB (2004) The epidemiology of cholangiocarcinoma. Semin Liver Dis 24: 115\u2013125","journal-title":"Semin Liver Dis"},{"key":"BF6606086_CR19","doi-asserted-by":"publisher","first-page":"1273","DOI":"10.1056\/NEJMoa0908721","volume":"362","author":"J Valle","year":"2010","unstructured":"Valle J, Wasan H, Palmer DH, Cunningham D, Anthoney A, Maraveyas A, Madhusudan S, Iveson T, Hughes S, Pereira SP, Roughton M, Bridgewater J (2010) Cisplatin plus gemcitabine versus Gemcitabine for Biliary Tract Cancer. N Engl J Med 362: 1273\u20131281","journal-title":"N Engl J Med"},{"issue":"9","key":"BF6606086_CR20","doi-asserted-by":"publisher","first-page":"1422","DOI":"10.3748\/wjg.v13.i9.1422","volume":"13","author":"A Weber","year":"2007","unstructured":"Weber A, Landrock S, Schneider J, Stangl M, Neu B, Born P, Classen M, R\u00f6sch T, Schmid RM, Prinz C (2007) Long-term outcome and prognostic factors of patients with hilar cholangiocarcinoma. World J Gastroenterol 13 (9): 1422\u20131426","journal-title":"World J Gastroenterol"},{"key":"BF6606086_CR21","doi-asserted-by":"publisher","first-page":"129","DOI":"10.1007\/s004230050104","volume":"383","author":"CJ Yeo","year":"1998","unstructured":"Yeo CJ, Cameron JL (1998) Prognostic factors in ductal pancreatic cancer. Langenbeck's Arch Surg 383: 129\u2013133","journal-title":"Langenbeck's Arch Surg"}],"container-title":["British Journal of Cancer"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/www.nature.com\/articles\/6606086.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/articles\/6606086","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/articles\/6606086.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,5,18]],"date-time":"2023-05-18T12:49:09Z","timestamp":1684414149000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/6606086"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2011,1,25]]},"references-count":21,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2011,2]]}},"alternative-id":["BF6606086"],"URL":"https:\/\/doi.org\/10.1038\/sj.bjc.6606086","relation":{},"ISSN":["0007-0920","1532-1827"],"issn-type":[{"value":"0007-0920","type":"print"},{"value":"1532-1827","type":"electronic"}],"subject":[],"published":{"date-parts":[[2011,1,25]]}}}